Skip to content

Real-time Quantitative Optical Perfusion Imaging in Surgery

Real-time Quantitative Optical Perfusion Imaging in Surgery: a Prospective, Observational, In-vivo, Human, Single-center Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02902549
Enrollment
26
Registered
2016-09-16
Start date
2015-10-31
Completion date
2017-12-31
Last updated
2018-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of Perfusion

Keywords

Optical Coherence Tomography, Fluorescence Imaging, Sidestream Darkfield Microscopy, Laser Speckle Contrast Imaging

Brief summary

Surgeons are nowadays unable to visualize and quantitatively evaluate microvascularisation in real-time during surgery. Complications due to vascular compromise are a major problem, especially in reconstructive surgery. Poor blood perfusion leads to ischemia and even tissue necrosis. If, however, perfusion and ischemia could be monitored during surgery, then surgeons could change their reconstructive design and the anaesthesiologists could improve perfusion with fluids, inotropes or vasopressors, if necessary. Surgeons therefore need a tool that is able to image in high resolution (microvascularisation), direct, intra-operative, in 3D (to image thrombosis, luminal narrowing or distinct overlaying vessels) and that produces quantitative data to objectify image interpretation. Optical techniques, based on the interaction of light with tissue, are able to image tissue at high resolution and in real-time. These techniques are FDA-approved and have emerged as powerful diagnostic tools in different departments of medicine, such as ophthalmology for visualizing retina vascularisation and dermatology for skin diagnostics. In this study, investigators hypothesize that four novel optical technologies: Fluorescence Imaging, Laser Speckle Contrast Imaging, Optical Coherence Tomography and Sidestream Darkfield Microscopy are able to quantitatively image perfusion in real-time during surgery.

Detailed description

Primary objective - Perfusion will be measured with all the techniques focussed on 4 areas; from 'good' to 'decreased' perfusion (biologically) Fluorescence Imaging (FI): Time to intensity measurements at four sides Laser Speckle Contrast Imaging (LSCI): Perfusion Units Optical Coherence Tomography (OCT): Vessel density & decorrelation time Sidestream Darkfield Microscopy (SDF): Total vessel density, proportion of perfused vessels, perfused vessel density, max flow index, De Backer score, perfusion in mm/sec. Differences in parameters between the four sites will be statistically be compared. Secondary objectives \- Relation of parameters to patient outcome in terms of adverse events.

Interventions

None listed

Sponsors

Quest Medical Imaging
CollaboratorINDUSTRY
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years - Scheduled for reconstructive surgery with free flap reconstruction or laparoscopic transhiatal and 3-stage transthoracic gastric tube surgery.

Exclusion criteria

* Allergic to iodide (indocyanine green) * Hyper-thyroidism * Breastfeeding * No informed consent * Allergic to ephedrine * Ischaemic heart disease * Thyrotoxicosis * Autonomic thyroid adenomas * Intraoperative hypertension or tachycardia

Design outcomes

Primary

MeasureTime frameDescription
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with OCT.1 year\- Perfusion will be imaged with OCT and measured in total vessel density.
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.1 yearPerfusion will be imaged with SDF and measured in microvascular flow index.
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with LSCI.1 yearflux in perfusion units (LSCI)
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with FI.1 yearintensity/time (FI)

Secondary

MeasureTime frameDescription
Distance of watershed to fundus (GT) or artery to tip (flap)1 yearIn the FI images the distance between the end of the right gastroepiploic artery and the fundus, and the distance between the artery entry and tip of the flap can be calculated.
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with SDF.1 yearPerfusion will be imaged with SDF and measured in total vessel density.
Measurement-time during surgery30 minutestime in minutes will be calculated during measurements
Number of participants with treatment-related adverse events as assessed by CTCAE v4.01 year
Difference in perfusion between the antrum and fundus (GT) or the artery origin and tip (free flap) measured with OCT.1 year\- Perfusion will be imaged with OCT and measured in decorrelation time.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026